跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NT-2
首页
药物
NT-2
NT-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of NT-814
US 12473260 B2
申请人: KANDY THERAPEUTICS LTD
优先权: 2019
CN
EP
US
WO
6 件公开
ANTIBODIES BINDING SPECIFICALLY TO NT-PROBNP AND USE THEREOF
EP 4169946 B1
申请人: BIONOTE INC
优先权: 2021
CN
EP
US
4 件公开
Peptide analogs that are potent and selective for human neurotensin preceptor subtype 2
US 2009062212 A1
申请人: RICHELSON ELLIOTT
优先权: 2007
US
3 件公开
Method and reagent for detecting ovarian clear cell adenocarcinoma
US 11193936 B2
申请人: PUBLIC UNIV CORP YOKOHAMA CITY UNIV
优先权: 2014
CN
US
2 件公开
BIOMARKER COMPOSITIONS AND METHODS OF USE THEREOF
US 20250027943 A1
申请人: SIEMENS HEALTHCARE DIAGNOSTICS INC
优先权: 2021
CN
US
2 件公开
New indole derivatives and their use as medicine
EP 1939195 A1
申请人: AETERNA ZENTARIS GMBH
优先权: 2001
EP
2 件公开
Fungicidal triazolopyrimidines, process for their preparation, their use for combatting fungi and agents comprising them
EP 1616870 A1
申请人: BASF AG
优先权: 2002
EP
2 件公开
High efficacy antisense RIalphaPKA poly-DNP oligoribonucleotides
US 7528117 B2
申请人: UNIV NEW YORK STATE RES FOUND
优先权: 2003
US
2 件公开
Triazolopyridine derivatives as p38 map kinase inhibitors
CN 103483338 A
申请人: CHIESI FARMA SPA
优先权: 2009
CN
2 件公开
Inhibitors of microRNAs that regulate production of atrial natriuretic peptide (ANP) as therapeutics and uses thereof
US 9388412 B2
申请人: GEN HOSPITAL CORP
优先权: 2013
US
2 件公开
第 1 / 7 页
上一页
下一页
药物
反馈